Richard A. Young

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Young:

Company Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp Director Common Stock 170,010 $280,516 $1.65 11 Sep 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 10,667 $17,880 $1.68 16 Sep 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 2,667 $4,470 $1.68 16 Sep 2024 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 20 Jun 2024 Direct
Camp4 Therapeutics Corp Director Stock Option (Right to Buy) 9,000 25 Jun 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6,000 05 Jun 2024 Direct
Camp4 Therapeutics Corp Director Series A Prime Preferred Stock 0 15 Oct 2024 Direct

Insider Reports Filed by Richard A. Young

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 11 Sep 2025 1 +$24,999 4 Director 11 Sep 2025, 16:22
CAMP Camp4 Therapeutics Corp 25 Jun 2025 1 $0 4 Director 27 Jun 2025, 16:03
CAMP Camp4 Therapeutics Corp 15 Oct 2024 2 $0 4 Director 15 Oct 2024, 17:46
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Director 10 Oct 2024, 21:01
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2024 2 $0 4 Director 18 Sep 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 28 Jun 2024 1 -$178,365 4 Director 02 Jul 2024, 16:15
OMGAQ Omega Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:20
SYRS Syros Pharmaceuticals, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:30
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2023 2 $0 4 Director 19 Sep 2023, 17:48
OMGAQ Omega Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
OMGAQ Omega Therapeutics, Inc. 02 Jun 2023 1 -$40,000 4 Director 05 Jun 2023, 16:15
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:27
OMGAQ Omega Therapeutics, Inc. 01 May 2023 1 -$40,000 4 Director 03 May 2023, 16:05
OMGAQ Omega Therapeutics, Inc. 06 Apr 2023 1 -$40,000 4 Director 10 Apr 2023, 16:05
OMGAQ Omega Therapeutics, Inc. 17 Mar 2023 1 -$80,000 4 Director 20 Mar 2023, 16:05
OMGAQ Omega Therapeutics, Inc. 10 Jan 2023 1 -$160,000 4 Director 11 Jan 2023, 15:14
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 2 $0 4 Director 19 Sep 2022, 17:16
OMGAQ Omega Therapeutics, Inc. 14 Sep 2022 1 -$80,000 4 Director 15 Sep 2022, 16:10
OMGAQ Omega Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:10
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:09
OMGAQ Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Director, 10%+ Owner 29 Jul 2021, 21:04
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:31